Company Filing History:

20 out of 197

Boehringer Ingelheim Kg

patents

5 out of 306

Boehringer Ingelheim Gmbh

patents

4 out of 149

Boehringer Ingelheim Pharma Kg

Boehringer Ingelheim Pharma Gmbh & Co Kg

patents

Years Active: 1985-2006

Loading Chart...

32 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7084140 - Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds (2006-08-01),

2. 6664253 - Neurokinin antagonists (2003-12-16),

3. 6498162 - Arylglycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds (2002-12-24),

4. 6413959 - Method of treating depression with arylglycinamide derivatives (2002-07-02),

5. 6303601 - Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds (2001-10-16),

6. 6294556 - Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds (2001-09-25),

7. 6277840 - Neurokinin antagonists, processes for preparing them and pharmaceutical compositions containing these compounds (2001-08-21),

8. 6251909 - Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds (2001-06-26),

9. 6235732 - Neurokinin antagonists (2001-05-22),

10. 6232468 - Dipeptides with neurokinin-antagonistic activity (2001-05-15),

11. 6191135 - Neurokinin antagonists (2001-02-20),

12. 6147212 - Amino acid derivatives, processes for the manufacture thereof and (2000-11-14),

13. 6124296 - Arylglycinamide derivatives, methods of producing these substances and (2000-09-26),

14. 6121262 - Arylglycinamide derivatives, processes for the manufacture thereof and (2000-09-19),

15. 6103719 - Neurokinin antagonists, processes for preparing them and pharmaceutical (2000-08-15),

Title: The Innovative Journey of Inventor Gerd Schnorrenberg

Introduction: Gerd Schnorrenberg, a talented inventor hailing from Gau-Algesheim, DE, has left a significant mark in the field of pharmaceuticals with his numerous patents.

Latest Patents: Among his impressive portfolio of 32 patents, one of the latest inventions includes arylglycinamide derivatives. These compounds, along with neurokinin antagonists, have opened new avenues in the realm of pharmaceutical compositions.

Career Highlights: Gerd Schnorrenberg has lent his expertise to renowned companies such as Boehringer Ingelheim KG and Boehringer Ingelheim GmbH, showcasing his innovative capabilities in diverse settings.

Collaborations: Throughout his career, Gerd Schnorrenberg has collaborated with esteemed professionals in the field, including coworkers such as Horst Dollinger and Birgit Jung. This teamwork has further fueled his inventive spirit and led to groundbreaking discoveries.

Conclusion: In conclusion, Gerd Schnorrenberg's journey as an inventor exemplifies dedication, creativity, and a relentless pursuit of innovation. His contributions to the world of pharmaceuticals continue to inspire and make a lasting impact.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.